![]() |
市场调查报告书
商品编码
1396585
临床资料管理系统 (CDMS) 市场 - 按交付模式(许可企业解决方案、基于云端的解决方案)、最终用途(合约研究组织、医疗器材公司)、全球预测(2023 年 - 2032 年)Clinical Data Management Systems (CDMS) Market - By Delivery Mode (Licensed Enterprise Solutions, Cloud-based Solutions), By End-use (Contract Research Organizations, Medical Device Companies), Global Forecast (2023 - 2032) |
由于医疗保健资料数位化程度不断提高以及对资料安全性和合规性的日益重视,临床资料管理系统 (CDMS) 市场规模从 2023 年到 2032 年的CAGR预计将达到 11.2%。根据美国医学协会 (AMA) 2022 年数位医疗保健研究结果,选择数位医疗工具进行病患照护的医生数量从 2016 年的 85% 增长到 2022 年的 93%。
CDMS 解决方案的需求量很大,因为它们有助于优先考虑资料加密、存取控制以及遵守资料保护法规。在医疗保健和生命科学领域,这些解决方案有助于减轻与资料外洩和网路攻击相关的风险。增加与强大的安全功能(包括审计追踪和监控功能)的整合也将决定市场的成长。
整个 CDMS 产业分为交付模式、最终用途和区域。
在交付模式方面,从2023年到2032年,授权企业(本地)解决方案领域的市场份额将以超过10%的CAGR扩大。这可以归因于人们越来越偏好本地 CDMS 解决方案,因为它们为组织提供了对资料安全性和合规性的更大控制。这些解决方案还提供整个软体环境的高水准客製化和控制。具有大型资料集和特定效能要求的组织也会选择本地 CDMS 技术来确保最佳化效能。
基于最终用途,由于简化和管理收集、分析和报告临床试验资料的复杂流程的需求激增,医疗器材公司细分市场的临床资料管理系统产业价值从 2023 年到 2032 年可能会增长 9.6% 。 CDMS 凭藉其电子资料撷取 (EDC) 功能,有助于简化资料收集过程。即时资料输入、减少对纸本方法的依赖以及最大限度地降低资料转录错误的风险等优势也将促进该细分市场的成长。
从地区来看,预计到 2032 年,亚太地区 CDMS 市场规模的CAGR将达到 13.2%,原因是行动和穿戴式技术的不断融合,以确保即时资料采集、患者参与和监测,以实现更多以病人为中心的临床试验。随着医疗保健资料数位化的不断发展,对资料安全性和监管要求合规性的重视显着提高。资料管理实践标准化的不断努力将推动区域产业扩张。
Clinical Data Management Systems (CDMS) Market size is poised to record 11.2% CAGR from 2023-2032, on account of the increasing digitization of healthcare data and the heightened emphasis on data security and compliance. As per the American Medical Association (AMA) digital health care 2022 study findings, the number of physicians opting for digital health tools for patient care grew from 85% in 2016 to 93% in 2022.
CDMS solutions are witnessing significant demand as they help to prioritize data encryption as well as access controls and compliance with data protection regulations. In healthcare and life sciences sectors, these solutions help mitigate the risks associated with data breaches and cyberattacks. Increasing integration with robust security features, including audit trails and monitoring capabilities will also define the market growth.
The overall CDMS industry is segmented into delivery mode, end-use, and region.
In terms of delivery mode, the market share from the licensed enterprise (on-premise) solutions segment will expand at over 10% CAGR from 2023-2032. This can be attributed to the growing preference for on-premise CDMS solutions as they offer greater control to organizations over data security and compliance. These solutions also provide high level of customization and control throughout the software environment. Organizations with large datasets and specific performance requirements also opt for on-premise CDMS technology to ensure optimized performance.
Based on end-use, the clinical data management systems industry value from the medical device companies segment may witness 9.6% growth rate from 2023-2032 driven by the surging need to streamline and manage complex processes of collecting, analyzing, and reporting clinical trial data. CDMS helps simplify the process of data collection on account of its electronic data capture (EDC) capabilities. Advantages, such as real-time data entry, reduced reliance on paper-based methods and minimized risk of data transcription errors will also boost the segment growth.
Regionally, the Asia Pacific CDMS market size is projected to record 13.2% CAGR through 2032 owing to the rising integration of mobile and wearable technologies to ensure real-time data capture, engagement patient and monitoring for more patient-centric clinical trials. With increasing digitization of healthcare data, the emphasis on data security and compliance with regulatory requirements has significantly heightened. The increasing efforts led towards standardization of data management practices will push the regional industry expansion.